Literature DB >> 1431229

Quantitative determination of EGF-R during epidermal wound healing.

C M Stoscheck1, L B Nanney, L E King.   

Abstract

Little is known about the intrinsic regulation of growth factors of cytokines during the normal epidermal wound-healing processes in skin. A simplified model of wounding (tape stripping to remove the stratum corneum) was used to study the role of epidermal growth factor receptors (EGF-R) in this process. Although the dynamics of EGF-R in epidermal wound healing have not been determined, the immunoreactive EGF-R that are present presumably play an active role. Prior studies show that 1) EGF-R are present in increased numbers in proliferative skin diseases; 2) a hypertrophic epidermis, closely resembling normal wound healing, is induced in mouse skin by EGF injections; and 3) exogenous topical EGF potentiates wound healing. The number of immunoreactive receptors as measured by an enzyme-linked immunosorbent assay (ELISA) and histologic methods increased prior to an increase in epidermal thickness, total protein, and DNA content. This early increase in the levels of EGF-R was followed by a sharp decline in EGF-R and subsequent decline in epidermal thickness (hypertrophy), total protein, and DNA levels. Alterations in the temporal sequence in these parameters indicate that the EGF-R-mediated signaling systems play an active role in epidermal wound repair.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431229     DOI: 10.1111/1523-1747.ep12668143

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

1.  Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.

Authors:  S Stoll; W Garner; J Elder
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  The skinny on Slug.

Authors:  Stephanie H Shirley; Laurie G Hudson; Jing He; Donna F Kusewitt
Journal:  Mol Carcinog       Date:  2010-10       Impact factor: 4.784

3.  Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.

Authors:  J Gille; R A Swerlick; S W Caughman
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

Review 4.  Microgravity and the implications for wound healing.

Authors:  Ramin Mostofizadeh Farahani; Luisa A DiPietro
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

5.  Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis.

Authors:  M J Gerritsen; P E van Erp; I M van Vlijmen-Willems; L T Lenders; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  The effects of ageing on wound healing: immunolocalisation of growth factors and their receptors in a murine incisional model.

Authors:  G S Ashcroft; M A Horan; M W Ferguson
Journal:  J Anat       Date:  1997-04       Impact factor: 2.610

7.  Increased levels of keratin 16 alter epithelialization potential of mouse skin keratinocytes in vivo and ex vivo.

Authors:  M J Wawersik; S Mazzalupo; D Nguyen; P A Coulombe
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

8.  Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

Authors:  Stephen Hiscox; Liam Morgan; Denise Barrow; Carol Dutkowskil; Alan Wakeling; Robert I Nicholson
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

9.  Epigenetic reprogramming during wound healing: loss of polycomb-mediated silencing may enable upregulation of repair genes.

Authors:  Tanya Shaw; Paul Martin
Journal:  EMBO Rep       Date:  2009-07-03       Impact factor: 8.807

10.  Slug/Snai2 is a downstream mediator of epidermal growth factor receptor-stimulated reepithelialization.

Authors:  Donna F Kusewitt; Changsun Choi; Kimberly M Newkirk; Pascale Leroy; Yafan Li; Miquella G Chavez; Laurie G Hudson
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.